What sector does Tatva Chin Pharm Chem Ltd belong to?

Tatva Chin Pharm Chem Ltd operates in the Commodities sector, specifically the Specialty Chemicals industry, and is listed on the NSE.

What is the current share price of TATVA?

As of the latest available quote, TATVA traded at ₹1,602.10. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of TATVA?

Tatva Chin Pharm Chem Ltd has a price-to-earnings (P/E) ratio of about 72.69. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of TATVA?

The market capitalisation of Tatva Chin Pharm Chem Ltd is approximately ₹3,763 Cr.

Is Tatva Chin Pharm Chem Ltd profitable?

For its latest reported financial year, Tatva Chin Pharm Chem Ltd recorded a net profit margin of about 8.30%.

Does TATVA pay a dividend?

Tatva Chin Pharm Chem Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of TATVA?

Tatva Chin Pharm Chem Ltd has a return on equity (ROE) of about 5.54%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of TATVA?

Over the past 52 weeks, TATVA has traded between a low of ₹981.50 and a high of ₹1,838.10.

Tatva Chin Pharm Chem Ltd

TATVA NSE Commodities Specialty Chemicals

₹1,602.10

-3.44%

Delayed · cached 15 min

Fair value analysis

TATVA

Tatva Chin Pharm Chem Ltd

₹1,659.20

Close used for this calculation

₹536.32Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

26/100

Profitability11/25

Returns2/25

Balance Sheet11/25

Efficiency2/25

Growth1/25

Weak

Quality radar

Consensus fair value

₹536.32

Above FV

▼ -67.7% against the close used

Model range ₹35.96 – ₹582.46

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹35.96Fair value₹536.32Bull₹582.46

FairClose

52-week traded range

52W low ₹991.5052W high ₹1,800.10

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Tatva Chin Pharm Chem Ltd closed at ₹1,659.20, 209.4% above the consensus fair value of ₹536.32 drawn from 9 valuation models.

Financial DNA score 26/100 — Weak. P/E of 71.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹238.50

-85.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=2%, r=10%, tg=3%, n=10yr

Graham Number

₹416.47

-74.9%

√(22.5 × EPS × BVPS)

EPS=17.98, BVPS=428.73 · outside Graham range (P/E 71.8, P/B 3.9) — asset-light, treat as a rough floor

Graham Formula

₹208.70

-87.4%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=2%, FD=7%

P/E Fair Value

₹537.60

-67.6%

EPS × 29.9x (sector P/E)

EPS=17.98, Sector P/E=29.9x

Peter Lynch (PEG)

₹35.96

-97.8%

EPS × Growth% (PEG = 1 is fair)

EPS=17.98, g=2%

EV/EBITDA

₹582.46

-64.9%

(EBITDA × 11x − Net Debt) ÷ Shares

EBITDA=1.31B

Book Value (P/B)

₹155.57

-90.6%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=428.73, ROE=5.5%, g=3%, r=10%

Reverse DCF

₹1,659.20

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 28% | Historical: 2%

Margin of Safety

₹262.74

-84.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=350.32, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer